https://www.bseindia.com/corporates/anndet_new.aspx?newsid=82c74792-4ada-4785-a020-d376f6c34d1d
Shilpa Medicare Ltd, a Raichur (Karnataka) based pharmaceutical company, dedicated in providing world class Oncology and Non-Oncological products to patients across the geographies, announces yet another innovation in treatment of Colorectal and Metastatic Breast Cancer. The company has introduced Capecitabine 1000 MG dispersible tablet for the first time in the world, with novel technology of faster dispersion within 90 seconds. The Company has launched the product in the Indian market on 16th Dec’22 and is further looking to introduce Capebel 1 gm DT in various international markets through our partners and clients.
| Subscribe To Our Free Newsletter |
